Healthcare [ 4/11 ] | Biotechnology [ 53/112 ]
US | NASDAQ | Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 23 | -0.26 Increased by +21.21% | -0.24 Decreased by -34.72% |
| Mar 30, 23 | -0.21 Increased by +25.00% | -0.25 Increased by +64.00% |
| Nov 9, 22 | -0.30 Increased by +9.09% | -0.28 Decreased by -25.51% |
| Aug 11, 22 | -0.32 Increased by +86.61% | -0.30 Decreased by -22.22% |
| May 11, 22 | -0.33 | -0.29 Decreased by -47.56% |
| Mar 22, 22 | -0.28 | -0.25 Decreased by -48.00% |
| Nov 9, 21 | -0.33 | -0.19 Decreased by -387.81% |
| Sep 7, 21 | -2.39 | -0.85 Decreased by -213.15% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 23 | 1.27 M Increased by +54.95% | -23.36 M Increased by +20.81% | Decreased by -1.84 K% Increased by +48.89% |
| Dec 31, 22 | 1.56 M Increased by +7.23% | -19.47 M Increased by +22.63% | Decreased by -1.25 K% Increased by +27.85% |
| Sep 30, 22 | 2.37 M Increased by +53.93% | -27.26 M Decreased by -15.34% | Decreased by -1.15 K% Increased by +25.07% |
| Jun 30, 22 | 1.00 M Increased by +37.64% | -28.68 M Increased by +30.38% | Decreased by -2.86 K% Increased by +49.42% |
| Mar 31, 22 | 819.00 K Decreased by -22.95% | -29.49 M Decreased by -169.06% | Decreased by -3.60 K% Decreased by -249.22% |
| Dec 31, 21 | 1.45 M Decreased by -46.77% | -25.17 M Decreased by -409.54% | Decreased by -1.73 K% Decreased by -857.31% |
| Sep 30, 21 | 1.54 M Increased by +68.01% | -23.63 M Decreased by -530.58% | Decreased by -1.54 K% Decreased by -275.31% |
| Jun 30, 21 | 728.00 K Increased by +29.08% | -41.20 M Decreased by -1.27 K% | Decreased by -5.66 K% Decreased by -961.07% |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.